Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Anebulo Pharmaceuticals Inc. Common Stock
ANEB | US
0.36
USD-0.01
-3.95%
ANEB | US
Loading StockChartView...
About Anebulo Pharmaceuticals Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
08/06/2026
Close
0.36
Open
0.37
High
0.37
Low
0.35
Anebulo Pharmaceuticals Inc. a clinical-stage biotechnology company engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. Its lead product candidate is ANEB-001 a small molecule cannabinoid receptor antagonist which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. The company was incorporated in 2020 and is based in Lakeway Texas.
View LessANEB | US
Risk
116.7
Sharpe
-0.49
Luna's Score
30/100
Recommendation
Sell
Luna says (ANEB | US)
What's Working
What's not Working
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
101.6%1 month
116.7%3 months
164.7%6 months
161.2%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
12.45
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-6.54
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
9.34M
MarketCap(USD)
9.34M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-113.80
Short ratio
0.94
Short perc.
0.37
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.15
Range1M
0.17
Range3M
0.77
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
2.30
Price X volume
3.12K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -6.54 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 12.45 | 15.55 | Par |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 164.69 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 9.34M | 3.66B | Emerging |
